TrialPloS one2018

TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.

Eriza Cristina Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.